• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因帕金森病多巴胺激动剂治疗而导致的可卡因吸食。

Crack cocaine use due to dopamine agonist therapy in Parkinson disease.

机构信息

Butler Hospital, Warren Alpert School of Medicine of Brown University, Providence, RI, USA.

出版信息

Neurology. 2013 Jun 11;80(24):2269-70. doi: 10.1212/WNL.0b013e318296e9d5. Epub 2013 May 15.

DOI:10.1212/WNL.0b013e318296e9d5
PMID:23677745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3721099/
Abstract

Impulse control disorders (ICD) and the dopamine dysregulation syndrome (DDS) are dopaminergic complications of Parkinson disease (PD) treatment. A large number of ICDs have been associated with dopamine agonists (DAA), such as gambling, hypersexuality, and consumerism, but none, to our knowledge, involved drugs of abuse. DDS is a condition in which patients with PD abuse l-dopa, taking it excessively despite the dyskinesias or psychotic symptoms that result. DDS produces l-dopa craving, whereas ICDs produce compulsions, and the 2 may coexist. DDS has rarely been associated with dopamine agonists other than apomorphine.

摘要

冲动控制障碍(ICD)和多巴胺失调综合征(DDS)是帕金森病(PD)治疗的多巴胺能并发症。大量的 ICD 与多巴胺激动剂(DAA)有关,如赌博、性欲亢进和消费主义,但据我们所知,没有一种与滥用药物有关。DDS 是一种 PD 患者滥用左旋多巴的疾病,尽管会出现运动障碍或精神病症状,但仍过度服用。DDS 会产生左旋多巴的渴望,而 ICD 会产生强迫,两者可能并存。除了阿朴吗啡外,DDS 很少与其他多巴胺激动剂有关。

相似文献

1
Crack cocaine use due to dopamine agonist therapy in Parkinson disease.因帕金森病多巴胺激动剂治疗而导致的可卡因吸食。
Neurology. 2013 Jun 11;80(24):2269-70. doi: 10.1212/WNL.0b013e318296e9d5. Epub 2013 May 15.
2
Daytime sleepiness, agonist therapy, and driving in Parkinson disease.帕金森病中的日间嗜睡、激动剂治疗与驾驶
JAMA. 2002;287(4):509-11. doi: 10.1001/jama.287.4.509.
3
Fixed-drug reaction secondary to cocaine use.可卡因使用继发的固定性药疹。
Skinmed. 2015 Mar-Apr;13(2):153-4.
4
Brown-Sequard syndrome after esophageal sclerotherapy and crack cocaine abuse.食管硬化剂治疗及滥用快克可卡因后出现的布朗-塞卡尔综合征
Neurology. 2002 Apr 9;58(7):1129-30. doi: 10.1212/wnl.58.7.1129.
5
Crack eye.眼角有裂纹。(不太确定这个表述是否准确,“Crack eye”比较罕见和不太常规的表达,或许有更合适的语境来准确理解其确切意思)
J Emerg Med. 2009 Jul;37(1):75-6. doi: 10.1016/j.jemermed.2007.06.036. Epub 2008 Jan 18.
6
Compulsive singing associated with a dopamine agonist in Parkinson disease.帕金森病中与多巴胺激动剂相关的强迫性歌唱。
Cogn Behav Neurol. 2010 Jun;23(2):140-1. doi: 10.1097/WNN.0b013e3181c12af2.
7
[Pulmonary complications related to cocaine consumption].[与可卡因使用相关的肺部并发症]
An Med Interna. 1999 Jul;16(7):371-9.
8
Peripheral edema and dopamine agonists in Parkinson disease.帕金森病中的周围性水肿与多巴胺激动剂
Arch Neurol. 2007 Oct;64(10):1546-7; author reply 1547. doi: 10.1001/archneur.64.10.1546-b.
9
Cocaine abuse in the elderly: a series of three case reports.老年人可卡因滥用:三例病例报告系列
J Nerv Ment Dis. 2002 Aug;190(8):562-5. doi: 10.1097/00005053-200208000-00014.
10
Lack of neurotoxic effect of diethylpropion in crack-cocaine abusers.安非拉酮对快克可卡因滥用者无神经毒性作用。
Clin Neuropharmacol. 1996 Feb;19(1):52-8. doi: 10.1097/00002826-199619010-00003.

引用本文的文献

1
Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management.帕金森病相关冲动控制障碍:风险因素、发病机制及药物治疗概述。
CNS Drugs. 2024 Jun;38(6):443-457. doi: 10.1007/s40263-024-01087-y. Epub 2024 Apr 13.
2
Psychomotor Symptoms in Chronic Cocaine Users: An Interpretative Model.慢性可卡因使用者的精神运动症状:一种解释模型。
Int J Environ Res Public Health. 2022 Feb 8;19(3):1897. doi: 10.3390/ijerph19031897.
3
A Neurobehavioral Approach to Addiction: Implications for the Opioid Epidemic and the Psychology of Addiction.神经行为方法对成瘾的研究:对阿片类药物流行和成瘾心理学的启示。
Psychol Sci Public Interest. 2019 Oct;20(2):96-127. doi: 10.1177/1529100619860513.
4
Evolving Concepts of Emotion and Motivation.情感与动机的演变概念
Front Psychol. 2018 Sep 7;9:1647. doi: 10.3389/fpsyg.2018.01647. eCollection 2018.
5
Liking, wanting, and the incentive-sensitization theory of addiction.喜好、欲求与成瘾的动机敏感化理论
Am Psychol. 2016 Nov;71(8):670-679. doi: 10.1037/amp0000059.
6
Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's Disease.冲动控制障碍对帕金森病睡眠-觉醒调节的影响
Parkinsons Dis. 2015;2015:970862. doi: 10.1155/2015/970862. Epub 2015 Nov 18.
7
Pleasure systems in the brain.大脑中的奖赏系统。
Neuron. 2015 May 6;86(3):646-64. doi: 10.1016/j.neuron.2015.02.018.
8
Monoamine reuptake inhibitors in Parkinson's disease.单胺再摄取抑制剂在帕金森病中的应用。
Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25.
9
Impulsive and compulsive behaviors in Parkinson's disease.帕金森病中的冲动和强迫行为。
Annu Rev Clin Psychol. 2014;10:553-80. doi: 10.1146/annurev-clinpsy-032813-153705. Epub 2013 Dec 2.

本文引用的文献

1
Dopaminergic dysregulation syndrome in Parkinson's disease.帕金森病多巴胺能调节障碍综合征。
J Neurol Sci. 2011 Nov 15;310(1-2):271-5. doi: 10.1016/j.jns.2011.07.012. Epub 2011 Aug 25.
2
Clinical aspects of impulsive compulsive behaviours in Parkinson's disease.帕金森病冲动强迫行为的临床方面。
J Neurol Sci. 2011 Nov 15;310(1-2):183-8. doi: 10.1016/j.jns.2011.07.031. Epub 2011 Aug 11.
3
Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding.帕金森病中的冲动控制障碍:寻求更好理解的路线图。
Brain Struct Funct. 2011 Nov;216(4):289-99. doi: 10.1007/s00429-011-0314-0. Epub 2011 May 4.
4
Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity.大鼠可卡因行为敏化:多巴胺 D3 和 D2 受体敏感性的时间差异证据。
Psychopharmacology (Berl). 2011 Jun;215(4):609-20. doi: 10.1007/s00213-010-2154-7. Epub 2011 Jan 5.
5
Inhaled cocaine used to relieve "off" periods in patients with Parkinson disease and unpredictable motor fluctuations: a report of 2 cases.吸入可卡因用于缓解帕金森病患者的“关”期及不可预测的运动波动:2例报告
J Clin Psychopharmacol. 2006 Dec;26(6):689-90. doi: 10.1097/01.jcp.0000245564.44778.d1.
6
Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.多巴胺D1样和D2样受体机制在可卡因觅药行为复发中的作用:选择性拮抗剂和激动剂的影响
J Pharmacol Exp Ther. 2000 Aug;294(2):680-7.